These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Significance of atypical endometrial cells detected by cervical cytology. Cherkis RC; Patten SF; Dickinson JC; Dekanich AS Obstet Gynecol; 1987 May; 69(5):786-9. PubMed ID: 3574808 [TBL] [Abstract][Full Text] [Related]
4. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas. Moatamed NA; Le LT; Levin MR; Govind R; Apple SK Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567 [TBL] [Abstract][Full Text] [Related]
5. [Relation between cervical smears and endometrial biopsy in proliferative lesions of the endometrium]. Duarte I; Perez A; Verni J; Sandoval M Rev Chil Obstet Ginecol; 1976; 41(2):99-101. PubMed ID: 1013439 [No Abstract] [Full Text] [Related]
6. Endometrial cells identified in cervical cytology in women > or = 40 years of age: criteria for appropriate endometrial evaluation. Beal HN; Stone J; Beckmann MJ; McAsey ME Am J Obstet Gynecol; 2007 Jun; 196(6):568.e1-5; discussion 568.e5-6. PubMed ID: 17547898 [TBL] [Abstract][Full Text] [Related]
7. Histiocytes and the detection of endometrial adenocarcinoma. Blumenfeld W; Holly EA; Mansur DL; King EB Acta Cytol; 1985; 29(3):317-22. PubMed ID: 3859129 [TBL] [Abstract][Full Text] [Related]
8. Endometrial metaplasia as a source of atypical glandular cells in cervicovaginal smears. Johnson TL; Kini SR Diagn Cytopathol; 1996 Feb; 14(1):25-31. PubMed ID: 8834073 [TBL] [Abstract][Full Text] [Related]
9. Endocyte endometrial smears in the cytodiagnosis of endometrial carcinoma. Byrne AJ Acta Cytol; 1990; 34(3):373-81. PubMed ID: 2343695 [TBL] [Abstract][Full Text] [Related]
10. Uterine lavage in the diagnosis of endometrial malignancy and its precursors. Barbaro CA; Fortune DW; Bodey AS; Hennessy E Acta Cytol; 1982; 26(2):135-40. PubMed ID: 6952713 [TBL] [Abstract][Full Text] [Related]
11. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086 [TBL] [Abstract][Full Text] [Related]
12. [Thr role of histiocytes in the cytodiagnosis of endometrial adenocarcinoma]. Zarcone R; Cardone G; Voto RI; Longo M; Cardone A Minerva Ginecol; 1992 Mar; 44(3):83-6. PubMed ID: 1565286 [TBL] [Abstract][Full Text] [Related]
13. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older. Browne TJ; Genest DR; Cibas ES Am J Clin Pathol; 2005 Dec; 124(6):834-7. PubMed ID: 16416731 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with a new endometrial cell sampling kit (Isaacs curity endometrium cell sampler) in the early detection of endometrial cancer. Feichter GE; Tauber PF; Landowski J Acta Cytol; 1982; 26(2):141-3. PubMed ID: 6952714 [TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]